Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer

Area of Science:

• Oncology
• Radiation Oncology
• Patient-Reported Outcomes

Background:

• Oral mucositis (OM) is a frequent and severe adverse effect of radiation therapy (RT) for head and neck cancer (HNC).
• Previous research on OM's clinical impact predates modern intensity-modulated RT (IMRT) and concurrent chemotherapy practices.

Purpose of the Study:

• To prospectively evaluate patient-reported OM severity in HNC patients receiving IMRT.
• To identify associations between OM severity and clinical outcomes, including quality of life.

Main Methods:

• A cohort of 702 HNC patients receiving IMRT were monitored weekly using the Oral Mucositis Weekly Questionnaire-Head and Neck Cancer survey.
• Statistical analyses included linear mixed models and Fisher exact tests to assess OM severity and clinical outcome correlations.
• Data from 576 eligible patients were analyzed.

Main Results:

• 62.5% of patients developed severe OM; 98.6% experienced some degree of OM.
• Higher OM severity was significantly associated with increased rates of feeding tube placement (P=.001), hospitalization (P=.02), opiate use (P<.001), and greater weight loss (P<.001).
• No significant differences in OM severity were found between different HNC disease sites.

Conclusions:

• Severe OM is highly prevalent in HNC patients treated with modern RT techniques.
• OM severity is a significant predictor of adverse clinical outcomes, including increased healthcare utilization and treatment toxicity.
• Enhanced strategies for OM prevention and management are crucial for improving patient care in HNC.